New tool helps heart patients weigh Blood-Thinner risks

NCT ID NCT07391358

Not yet recruiting Knowledge-focused Sponsor: Montreal Heart Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a patient decision aid designed to help heart attack survivors with high bleeding risk choose the best blood-thinner plan. The tool explains risks and options so patients can share their preferences with doctors. The trial will enroll 26 participants to see if the aid reduces confusion and improves knowledge. It is a beta test focused on usability, not on proving medical outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: patient decision aid
What this could lead to: If successful, this decision aid could help patients and doctors make better, more personalized choices about blood-thinner therapy after a heart attack.
What could go wrong: This is a very small, early-stage beta test (26 participants) focused on usability, not on health outcomes. The tool may not improve decisions or be adopted widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME

Contacts and locations

Locations

Montreal Heart Institute

Montreal, Quebec, H1T 1C8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.